NCT05250141View on ClinicalTrials.gov

Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

February 17, 2022

Study Completion Date

February 17, 2022

Conditions
Bioequivalence
Interventions
DRUG

Levodopa 250mg and Carbidopa 25mg Test Drug tablet

Investigational Medicinal Product

DRUG

Levodopa 250mg and Carbidopa 25mg Referent Product tablet

Sinemet (Savio Industrial S.R.L, Brazil)

Trial Locations (1)

600048

Azidus Laboratories Ltd., Chennai

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT05250141 - Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product | Biotech Hunter | Biotech Hunter